Pleural fluid eosinophilia with combined pharmacotherapy.
Chiles
Catherine
C
van Wattum
Pieter Joost
PJ
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004155:Diphenhydramine / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010996:Pleural Effusion / Q000139:chemically induced* / Q000175:diagnosis; D011657:Pulmonary Eosinophilia / Q000139:chemically induced* / Q000175:diagnosis; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D014635:Valproic Acid; D004155:Diphenhydramine; D006220:Haloperidol